<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe the first three patients with a large granular <z:hpo ids='HP_0100827'>lymphocytosis</z:hpo>/lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and another blood <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In two, a <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> developed soon after the diagnosis of abnormal proliferation of large granular lymphocytes-natural killer (LGL-NK) cells, a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> evolving to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and a Philadelphia-positive <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In these cases, LGLs expressed the phenotype of CD3+ NK and CD3- NK cells, respectively, and were clonal in the first patient as demonstrated by T-cell receptor gene rearrangement study </plain></SENT>
<SENT sid="3" pm="."><plain>In the third case, a similarly clonal excess of LGLs, phenotypically CD3+ NK cells, was detected following a diagnosis of B-cell hairy-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Clinically, the concurrence of LGL proliferation and other <z:hpo ids='HP_0001909'>leukemia</z:hpo> did not seem to confer a worse prognosis on the patients </plain></SENT>
<SENT sid="5" pm="."><plain>Although an association by chance remains a possible explanation, a common origin from an altered precursor cell for both myeloid and LGL proliferations in the first two cases is discussed, whereas in the third it might be related to the severe immune derangement frequently observed in hairy-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>